Blue Cell Therapeutics is a biotechnology company developing novel stem cell therapies to cure chronic diseases.
Blue Cell Therapeutics has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.
Blue Cell Therapeutics's investors include Seier Capital.
Blue Cell Therapeutics is headquartered in Copenhagen, Denmark.
Blue Cell Therapeutics is a biotechnology company developing novel stem cell therapies to cure chronic diseases.
Blue Cell Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Blue Cell Therapeutics — Funding & Investors." VCBacked, October 24, 2024, https://www.vcbacked.co/company/blue-cell-therapeutics. Accessed August 17, 2026.
VCBacked. (2024). Blue Cell Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/blue-cell-therapeutics
{{cite web |title=Blue Cell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/blue-cell-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated